Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Investing activities | ||
| Purchases of marketable securities | (394,579) | (137,926) |
| Maturities and sales of marketable securities | 417,032 | 323,965 |
| Purchases of property and equipment | (3,271) | (9,356) |
| Cash paid to acquire finite-lived intangible asset | (28,800) | — |
| Net cash provided by (used in) investing activities | (9,618) | 176,683 |
| Financing activities | ||
| Proceeds from underwriter exercising option to purchase common stock, net of issuance costs | 12,366 | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s capex?
- Denali Therapeutics Inc. (DNLI) reported capex of $805K in Q2 2026.
- How has Denali Therapeutics Inc.'s capex changed year-over-year?
- Denali Therapeutics Inc.'s capex decreased by 81.2% year-over-year, from $4.28M to $805K.
- What is the long-term trend for Denali Therapeutics Inc.'s capex?
- Over 3 years (2021 to 2024), Denali Therapeutics Inc.'s capex has grown at a 23.2% compound annual growth rate (CAGR), from $8.5M to $15.91M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Denali Therapeutics Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude